JP2013100268A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013100268A5 JP2013100268A5 JP2012224722A JP2012224722A JP2013100268A5 JP 2013100268 A5 JP2013100268 A5 JP 2013100268A5 JP 2012224722 A JP2012224722 A JP 2012224722A JP 2012224722 A JP2012224722 A JP 2012224722A JP 2013100268 A5 JP2013100268 A5 JP 2013100268A5
- Authority
- JP
- Japan
- Prior art keywords
- disulfiram
- solvate
- acceptable salt
- liver cancer
- pharmacologically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- AUZONCFQVSMFAP-UHFFFAOYSA-N disulfiram Chemical compound CCN(CC)C(=S)SSC(=S)N(CC)CC AUZONCFQVSMFAP-UHFFFAOYSA-N 0.000 claims 10
- 229960002563 disulfiram Drugs 0.000 claims 5
- 201000007270 liver cancer Diseases 0.000 claims 5
- 208000014018 liver neoplasm Diseases 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 239000012453 solvate Substances 0.000 claims 5
- 210000000130 stem cell Anatomy 0.000 claims 5
- 239000003112 inhibitor Substances 0.000 claims 4
- 206010073071 hepatocellular carcinoma Diseases 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000001093 anti-cancer Effects 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012224722A JP6206939B2 (ja) | 2011-10-11 | 2012-10-10 | 肝がん幹細胞阻害剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011223639 | 2011-10-11 | ||
| JP2011223639 | 2011-10-11 | ||
| JP2012224722A JP6206939B2 (ja) | 2011-10-11 | 2012-10-10 | 肝がん幹細胞阻害剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013100268A JP2013100268A (ja) | 2013-05-23 |
| JP2013100268A5 true JP2013100268A5 (https=) | 2015-11-26 |
| JP6206939B2 JP6206939B2 (ja) | 2017-10-04 |
Family
ID=48621310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012224722A Expired - Fee Related JP6206939B2 (ja) | 2011-10-11 | 2012-10-10 | 肝がん幹細胞阻害剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6206939B2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10722480B2 (en) | 2015-01-06 | 2020-07-28 | Tokyo University Of Science Foundation | Agent for controlling cells constituting cancer microenvironment or inflammatory microenvironment |
| KR101765575B1 (ko) * | 2015-02-02 | 2017-08-07 | 연세대학교 산학협력단 | 알데히드 억제제 및 비구아나이드 계열 화합물을 포함하는 암 줄기세포의 성장 억제용 약학적 조성물 |
| US12521362B2 (en) | 2019-07-25 | 2026-01-13 | Tokyo University Of Science Foundation | Agent for treating, preventing, or improving psychiatric and nervous system disorders or symptoms |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL122892A0 (en) * | 1998-01-11 | 1998-08-16 | Yeda Res & Dev | Pharmaceutical compositions comprising a thiocarbamate |
-
2012
- 2012-10-10 JP JP2012224722A patent/JP6206939B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014530840A5 (https=) | ||
| WO2016034946A3 (en) | Thienopyrroles as histone demethylase inhibitors | |
| PH12015502628B1 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of disease | |
| MX2015017964A (es) | Inhibidores de bromodominio. | |
| DK3313991T3 (da) | Modificeret faktor ix og sammensætninger, fremgangsmåder og anvendelser til genoverførsel til celler, organer og væv | |
| CL2015000829A1 (es) | Inhibidores de histona desmetilasas | |
| MX2015016344A (es) | Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades. | |
| MX345928B (es) | Composiciones terapeuticamente activas y metodos de uso de las mismas. | |
| JP2012126725A5 (https=) | ||
| TN2016000017A1 (en) | Piperidinyl indole derivatives and their use as complement factor b inhibitors | |
| MX346224B (es) | Composiciones y metodos para el tratamiento de inflamacion cronica y enfermedades inflamatorias. | |
| MX2015016421A (es) | Derivados de pirazolo-pirrolidin-4-ona como inhibidores de bet y su uso en el tratamiento de enfermedades. | |
| CL2014002386A1 (es) | Compuesto inhibidor de cinasa de fosfoinositida 3 en forma anhidra cristalina solida; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento o prevencion de enfermedades tales como epoc, asma, entre otras. | |
| CR20150432A (es) | Estra-1,3,5 (10), 16-tetraeno-3-carboxamidas para la inhibición de la 17b-hidroxiesteroide deshidrogenasa (akr1 c3) | |
| UA115357C2 (uk) | Похідні піридин-4-ілу | |
| WO2013134407A3 (en) | Procaspase 3 activation by combination therapy | |
| CL2014001861A1 (es) | Compuestos derivados de bencil sulfonamida, inhibidores de mogat-2; compuesto cristalino; composicion farmaceutica; y su uso en el tratamiento de la hipertrigliceridemia. | |
| CL2014001863A1 (es) | Sal fosfato de dihidropirrolo [1,2-c] imidazolilo, inhibidor de la aldosterona sintasa o aromatasa; forma cristalina a; sal nitrato; procedimiento para preparar una sal nitrato o fosfato cristalina; composicion farmaceutica; y su uso para el tratamiento del sindrome de cushing. | |
| MX2015007940A (es) | Compuestos tricíclicos como inhibidores de cftr. | |
| JP2013231052A5 (https=) | ||
| EA201491532A1 (ru) | Фармацевтические композиции для использования в комплексной терапии | |
| TN2014000060A1 (en) | Benzothiazolone compound | |
| JP2013100268A5 (https=) | ||
| CL2013001445A1 (es) | Compuestos derivados de difenilamina; composicion farmaceutica y uso en el tratamiento de enfermedades inflamatorias, tales como cancer. | |
| BR112014004737A2 (pt) | composto de composição de cloridrato de ambroxol e método de preparação do composto |